-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
ADC Therapeutics SA annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- ADC Therapeutics SA Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2025 was $264,000, a 50% increase year-over-year.
- ADC Therapeutics SA annual Net Cash Provided by (Used in) Investing Activities for 2025 was $395,000.
- ADC Therapeutics SA annual Net Cash Provided by (Used in) Investing Activities for 2024 was $867,000, a 73% increase from 2023.
- ADC Therapeutics SA annual Net Cash Provided by (Used in) Investing Activities for 2023 was $3,216,000, a 368% decline from 2022.